Experiment 338313

Worktypes

PHARMACOLOGY OF COMPOUND - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGSANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)

Compounds isolated

PRODIGIOSAN

Details

PropertyValue
Pharmacology
IMMUNOSTIMULANT ACTIVITY
Administration routeIP
OrganismEmpty organism
CitationPEREL'MAN,AE: VISHNEVSKII,BI: VAVILIN,GI:. (1974). PRODIGIOSAN USED IN TREATMENT OF EXPERIMENTAL TUBERCULOSIS.. 19()
Amount utilized
Compound isolated
DiseaseENHANCED PHAGOCYTIC ACTIVITY TO M.TUBERCULOSIS DECREASED TUBERCULIN ALLERGY
Dose amount200.0 MCG
Number4
Qualitative resultACTIVE
AnimalMOUSE
Per unitKG
Dose expressionDOSE